Posted On: 09/11/2014 9:14:13 AM
Post# of 273352
Zenosense Inc (ZENO) 0.3100 $ZENO
Zenosense announces development of lung cancer detection device
M2 - Wed Jul 30, 3:34AM CDT
Zenosense Inc (OTCQB: ZENO), a healthcare technology company and a detection device development company, announced on Tuesday the expansion of its development operations to include a device intended to detect lung cancer in exhaled breath.
Zenosense, Inc. Begins Development of Lung Cancer Detection Device
Marketwire - Tue Jul 29, 7:31AM CDT
Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"
, a healthcare technology company primarily focused on developing and marketing a device to detect the MRSA "Super-Bug," is pleased to announce that it has expanded its development operations to include a device intended to detect lung cancer in exhaled breath.
Zenosense announces development of lung cancer detection device
M2 - Wed Jul 30, 3:34AM CDT
Zenosense Inc (OTCQB: ZENO), a healthcare technology company and a detection device development company, announced on Tuesday the expansion of its development operations to include a device intended to detect lung cancer in exhaled breath.
Zenosense, Inc. Begins Development of Lung Cancer Detection Device
Marketwire - Tue Jul 29, 7:31AM CDT
Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"
, a healthcare technology company primarily focused on developing and marketing a device to detect the MRSA "Super-Bug," is pleased to announce that it has expanded its development operations to include a device intended to detect lung cancer in exhaled breath.
(0)
(0)
